Cairo – Mubasher: October Pharma on Monday announced that its shareholders had approved the board of directors’ proposal to distribute a cash dividend of EGP 1 per share for 2018 during an ordinary general meeting (OGM), according to the firm’s statement to the Egyptian Exchange (EGX).
For the full-year 2018, October Pharma’s profits amounted to EGP 20.4 million, compared to EGP 55.15 million in the prior year.
